Duality Biotherapeutics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Mar '26 Mar 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Debt / Equity Ratio	0.02	0.00	0.00
Debt / EBITDA Ratio	-	-	0.01
Debt / FCF Ratio	0.10	0.02	0.01
Net Debt / Equity Ratio	-1.25	0.69	1.01
Net Debt / EBITDA Ratio	17.67	7.58	-1.53
Net Debt / FCF Ratio	-5.25	-4.94	-1.40
Asset Turnover	-	1.08	-
Quick Ratio	4.66	0.48	0.50
Current Ratio	4.73	0.49	0.52
Return on Assets (ROA)	-	-6.51%	-
Return on Capital Employed (ROCE)	-6.40%	10.50%	-69.40%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.